Skip to main content
. 2006 Nov 6;75(1):290–298. doi: 10.1128/IAI.00883-06

TABLE 2.

Identification of immunoreactive SCV and LCV proteins

No. Gene Description Predicted mass (kDa) Predicted pI Serum 2036
Serum 3004
Cell variant MS/MS identificationa Spot in other cell variant lysateb Cell variant MS/MS identificationa Spot in other cell variant lysateb
1 CBU1718 60-kDa chaperone (GroEL) 58.3 4.9 S + S+L NAc
2 CBU0236 Elongation factor EF-Tu 43.5 5.2 NA S+L NA
3 CBU0229 Ribosomal protein L7/L12 (RplJ) 13.2 4.4 S + S+L NA
4 CBU1943 ATP synthase F-1 alpha subunit (AtpA) 58.8 6.0 NA L +
5 CBU1416 Repressor protein C2 24.3 7.6 L NA
6 CBU0952 Acute disease antigen A (AdaA) 26.0 9.3 L + NA
7 CBU0963 Thioredoxin peroxidase (Bcp) 16.9 8.0 L NA
8 CBU0737 Trigger factor (Tig) 50.2 5.1 +d L
9 CBU0497 3-Oxoacyl-acyl carrier protein synthase II (FabF) 44.1 5.5 +d L +
10 CBU1200 Isocitrate dehydrogenase (Icd) 46.6 6.4 NA L +
a

Protein identified by mass spectrometry in lysates of the SCV (S), the LCV (L), or both (S+L).

b

Corresponding spot present in immunoblot of lysates derived from other cell variants is indicated with a +.

c

NA, not applicable.

d

Immunoreactive spot at the same coordinates in both SCV and LCV 2-D immunoblots as those of the protein identified by serum 3004 in the LCV.